Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletion

BMC Physiology

Volumn 12, Issue 1, 2012, Pages

  Sanders, Jennifer A ^a   Schorl, Christoph ^b,c   Patel, Ajay ^d   Sedivy, John M ^b,c   Gruppuso, Philip A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d MACNEAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMYLASE SALIVA ISOENZYME; AMY1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; PRENATAL DEVELOPMENT; REGENERATION;

ANIMALS; FEMALE; LIVER; MALE; MICE; MICE, KNOCKOUT; REGENERATION; SALIVARY ALPHA-AMYLASES;

EID: 84857740814     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-12-1     Document Type: Article

References (46)

1. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Mao DY, Watson JD, Yan PS, Barsyte-Lovejoy D, Khosravi F, Wong WW, et al. Curr Biol 2003 13 882 886 10.1016/S0960-9822(03)00297-5 12747840 (Pubitemid 36573259)
2. A large scale genetic analysis of c-Myc-regulated gene expression patterns. O'Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, Mateyak MK, et al. J Biol Chem 2003 278 12563 12573 10.1074/jbc.M210462200 12529326 (Pubitemid 36800246)
3. The Myc/Max/Mad network and the transcriptional control of cell behavior. Grandori C, Cowley SM, James LP, Eisenman RN, Annu Rev Cell Dev Biol 2000 16 653 699 10.1146/annurev.cellbio.16.1.653 11031250 (Pubitemid 32037520)
4. B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Gregory MA, Xiao Q, Cornwall GA, Lutterbach B, Hann SR, Oncogene 2000 19 4886 4895 10.1038/sj.onc.1203851 11039906
5. c-Myc as a therapeutic target in cancer. Prochownik EV, Expert Rev Anticancer Ther 2004 4 289 302 10.1586/14737140.4.2.289 15056059
6. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. Lin CP, Liu JD, Chow JM, Liu CR, Liu HE, Anticancer Drugs 2007 18 161 170 10.1097/CAD. 0b013e3280109424 17159602 (Pubitemid 44967426)
7. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice. Ohgaki H, Sanderson ND, Ton P, Thorgeirsson SS, Cancer Lett 1996 106 43 49 10.1016/0304-3835(96)04299-1 8827045 (Pubitemid 26306636)
8. c-Myc is required for the glucose-mediated induction of metabolic enzyme genes. Collier JJ, Doan TT, Daniels MC, Schurr JR, Kolls JK, Scott DK, J Biol Chem 2003 278 6588 6595 10.1074/jbc.M208011200 12480946 (Pubitemid 36800922)
9. Proto-oncogene expression and growth factors during liver regeneration. Fausto N, Mead JE, Braun L, Thompson NL, Panzica M, Goyette M, et al. Symp Fundam Cancer Res 1986 39 69 86 3321311
10. Liver regeneration. Steer CJ, FASEB J 1995 9 1396 1400 7589980
11. Sequential protooncogene expression during rat liver regeneration. Thompson NL, Mead JE, Braun L, Goyette M, Shank PR, Fausto N, Cancer Res 1986 46 3111 3117 3516391 (Pubitemid 16074336)
12. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Kim S, Li Q, Dang CV, Lee LA, Proc Natl Acad Sci USA 2000 97 11198 11202 11005843
13. Overexpression of c-myc in the liver prevents obesity and insulin resistance. Riu E, Ferre T, Hidalgo A, Mas A, Franckhauser S, Otaegui P, et al. FASEB J 2003 17 1715 1717 12958186
14. Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver. Riu E, Bosch F, Valera A, Proc Natl Acad Sci USA 1996 93 2198 2202 10.1073/pnas.93.5.2198 8700908 (Pubitemid 26079905)
15. Coordinated regulation of c-Myc and Max in rat liver development. Sanders JA, Gruppuso PA, Am J Physiol Gastrointest Liver Physiol 2006 290 145 G155 16150871
16. Nucleolar localization of hepatic c-Myc: a potential mechanism for c-Myc regulation. Sanders JA, Gruppuso PA, Biochim Biophys Acta 2005 1743 141 150 10.1016/j.bbamcr.2004.09.009 15777849 (Pubitemid 40380614)
17. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. de Alboran IM, O'Hagan RC, Gartner F, Malynn B, Davidson L, Rickert R, et al. Immunity 2001 14 45 55 10.1016/S1074-7613(01)00088-7 11163229 (Pubitemid 32144686)
18. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, et al. J Biol Chem 1999 274 305 315 10.1074/jbc.274.1.305 9867845 (Pubitemid 29035064)
19. Generalized lacZ expression with the ROSA26 Cre reporter strain. Soriano P, Nat Genet 1999 21 70 71 10.1038/5007 9916792 (Pubitemid 29036285)
20. Restoration of the liver of the white rat following partial removal. Higgins GM, Anderson RM, Arch Path Lab Med 1931 12 916 922
21. c-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death. de Alboran IM, Baena E, Martinez A, Cell Death Differ 2004 11 61 68 10.1038/sj.cdd.4401319 12970677 (Pubitemid 38111373)
22. Conditional gene knockout using Cre recombinase. Le Y, Sauer B, Mol Biotechnol 2001 17 269 275 10.1385/MB:17:3:269 11434315 (Pubitemid 32547928)
23. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A, Genes Dev 1993 7 671 10.1101/gad.7.4.671 8458579
24. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Postic C, Magnuson MA, Genesis 2000 26 149 150 10.1002/(SICI)1526- 968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V 10686614 (Pubitemid 30158104)
25. Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism. Riu E, Ferre T, Mas A, Hidalgo A, Franckhauser S, Bosch F, Biochem J 2002 368 931 937 10.1042/BJ20020605 12230428 (Pubitemid 36042696)
26. Rapamycin inhibits liver growth during refeeding in rats via control of ribosomal protein translation but not cap-dependent translation initiation. Anand P, Gruppuso PA, J Nutr 2006 136 27 33 16365054 (Pubitemid 43156480)
27. WNT/beta-catenin signaling in liver health and disease. Thompson MD, Monga SP, Hepatology 2007 45 1298 1305 10.1002/hep.21651 17464972 (Pubitemid 46775794)
28. Identification of c-MYC as a target of the APC pathway. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Science 1998 281 1509 1512 9727977 (Pubitemid 28425575)
29. Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy. Mayhew CN, Bosco EE, Fox SR, Okaya T, Tarapore P, Schwemberger SJ, et al. Cancer Res 2005 65 4568 4577 10.1158/0008-5472.CAN-04-4221 15930274 (Pubitemid 40740792)
30. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Romero-Gallo J, Sozmen EG, Chytil A, Russell WE, Whitehead R, Parks WT, et al. Oncogene 2005 24 3028 3041 10.1038/sj.onc.1208475 15735717 (Pubitemid 40675534)
31. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Mol Cell 2000 6 87 97 10949030
32. Variable expression of Cre recombinase transgenes precludes reliable prediction of tissue-specific gene disruption by tail-biopsy genotyping. Schulz TJ, Glaubitz M, Kuhlow D, Thierbach R, Birringer M, Steinberg P, et al. PLoS One 2007 2 1013 10.1371/journal.pone.0001013 17925861 (Pubitemid 351560153)
33. Variegated expression of a globin transgene correlates with chromatin accessibility but not methylation status. Garrick D, Sutherland H, Robertson G, Whitelaw E, Nucleic Acids Res 1996 24 4902 4909 10.1093/nar/24.24.4902 9016659 (Pubitemid 27007894)
34. Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus. Dobie KW, Lee M, Fantes JA, Graham E, Clark AJ, Springbett A, et al. Proc Natl Acad Sci USA 1996 93 6659 6664 10.1073/pnas.93.13.6659 8692874 (Pubitemid 26230365)
35. Age-dependent silencing of globin transgenes in the mouse. Robertson G, Garrick D, Wilson M, Martin DI, Whitelaw E, Nucleic Acids Res 1996 24 1465 1471 10.1093/nar/24.8.1465 8628679 (Pubitemid 26118979)
36. c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver. Baena E, Gandarillas A, Vallespinos M, Zanet J, Bachs O, Redondo C, et al. Proc Natl Acad Sci USA 2005 102 7286 7291 10.1073/pnas.0409260102 15857952 (Pubitemid 40696371)
37. Conditional deletion of c-myc does not impair liver regeneration. Li F, Xiang Y, Potter J, Dinavahi R, Dang CV, Lee LA, Cancer Res 2006 66 5608 5612 10.1158/0008-5472.CAN-05-4242 16740696 (Pubitemid 43927111)
38. Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. Zanet J, Pibre S, Jacquet C, Ramirez A, de Alboran IM, Gandarillas A, J Cell Sci 2005 118 1693 1704 10.1242/jcs.02298 15797928 (Pubitemid 40691897)
39. Distinct thresholds govern Myc's biological output in vivo. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, et al. Cancer Cell 2008 14 447 457 10.1016/j.ccr.2008.10.018 19061836
40. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, et al. Hepatology 2008 47 511 520 18161050 (Pubitemid 351280719)
41. c-myc overexpression in hepatocarcinogenesis. Feitelson MA, Hum Pathol 2004 35 1299 1302 10.1016/j.humpath.2004.09.012 15668885 (Pubitemid 39601568)
42. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. Calvisi DF, Thorgeirsson SS, Toxicol Pathol 2005 33 181 184 10.1080/01926230590522095 15805070 (Pubitemid 40216817)
43. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, et al. Mol Cancer Res 2005 3 403 412 10.1158/1541-7786.MCR-04- 0186 16046551 (Pubitemid 41045590)
44. Evidence from transgenic mice that myc regulates hepatic glycolysis. Valera A, Pujol A, Gregori X, Riu E, Visa J, Bosch F, FASEB J 1995 9 1067 1078 7649406
45. c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo. He C, Hu H, Braren R, Fong SY, Trumpp A, Carlson TR, et al. Development 2008 135 2467 2477 10.1242/dev.020131 18550710
46. c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. Bettess MD, Dubois N, Murphy MJ, Dubey C, Roger C, Robine S, et al. Mol Cell Biol 2005 25 7868 7878 10.1128/MCB.25.17.7868-7878.2005 16107730 (Pubitemid 41170145)